Coeptis Therapeutics Holdings, Inc. Files 2024 10-K
Ticker: COEPW · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1759186
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
Coeptis Therapeutics filed its 2024 10-K, detailing its financial health and business operations for the year ending Dec 31, 2024.
AI Summary
Coeptis Therapeutics Holdings, Inc. filed its 2024 10-K on March 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Bull Horn Holdings Corp., is involved in biological products and is incorporated in Delaware. Its principal executive offices are located in Wexford, Pennsylvania.
Why It Matters
This filing provides investors with a comprehensive overview of Coeptis Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual financial filing with no immediate red flags or significant new risks highlighted in the provided snippet.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-28 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Coeptis Therapeutics Holdings, Inc. (company) — Filer of the 10-K
- Bull Horn Holdings Corp. (company) — Former name of Coeptis Therapeutics Holdings, Inc.
- 2024-12-31 (date) — Fiscal year end for the 10-K report
- 2025-03-28 (date) — Filing date of the 10-K
- Wexford, Pennsylvania (location) — Location of Coeptis Therapeutics' business address
FAQ
What is the primary business of Coeptis Therapeutics Holdings, Inc.?
Coeptis Therapeutics Holdings, Inc. is involved in Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did Coeptis Therapeutics Holdings, Inc. change its name?
The company changed its name from Bull Horn Holdings Corp. on November 15, 2018.
Where is Coeptis Therapeutics Holdings, Inc. headquartered?
The company's business and mailing address is 105 Bradford Road, Suite 420, Wexford, PA 15090.
What is the SEC file number for Coeptis Therapeutics Holdings, Inc.?
The SEC file number for Coeptis Therapeutics Holdings, Inc. is 001-39669.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding Coeptis Therapeutics Holdings, Inc. (COEPW).